| 000 | 01849 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515102746.0 | ||
| 264 | 0 | _c20080515 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0707649 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBriggs, C A | |
| 245 | 0 | 0 |
_aalpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cMar 2008 |
||
| 300 |
_a1054-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xdrug effects |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xdrug effects |
| 650 | 0 | 4 | _aPC12 Cells |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xdrug effects |
| 650 | 0 | 4 |
_aTilorone _xadministration & dosage |
| 650 | 0 | 4 |
_aXanthones _xadministration & dosage |
| 650 | 0 | 4 | _aalpha7 Nicotinic Acetylcholine Receptor |
| 700 | 1 | _aSchrimpf, M R | |
| 700 | 1 | _aAnderson, D J | |
| 700 | 1 | _aGubbins, E J | |
| 700 | 1 | _aGrønlien, J H | |
| 700 | 1 | _aHåkerud, M | |
| 700 | 1 | _aWeen, H | |
| 700 | 1 | _aThorin-Hagene, K | |
| 700 | 1 | _aMalysz, J | |
| 700 | 1 | _aLi, J | |
| 700 | 1 | _aBunnelle, W H | |
| 700 | 1 | _aGopalakrishnan, M | |
| 700 | 1 | _aMeyer, M D | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 153 _gno. 5 _gp. 1054-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0707649 _zAvailable from publisher's website |
| 999 |
_c17668557 _d17668557 |
||